Table 1

Characteristics of patients with hypertrophic cardiomyopathy (HCM) and controls

HCM
n=101
Controls
n=30
P value
Age (years)49.7±12.151.5±14.10.48
Male, n (%)82 (82)23 (77)0.60
BSA (m2)2.03±0.261.97±0.210.32
Diabetes, n (%)17 (17)7 (23)0.43
Hypertension, n (%)44 (44)12 (40)0.83
Dyslipidaemia, n (%)21 (21)7 (23)0.80
LVEDVi (mL/m2)72.9±14.177.1±19.80.19
LVEF (%)74.1±7.764.8±9.3 <0.001
LV mass indexed (g/m2)87.0±28.355.0±13.0 <0.001
LGE, n (%)49 (49)0 (0) <0.001
Stress MBF (mL/g/min)1.62±0.602.31±0.64 <0.001
Rest MBF (mL/g/min)0.79±0.240.82±0.250.47
  • Data are presented as mean±SD unless stated. P values in bold are statistically significant.

  • BSA, body surface area; LGE, late gadolinium enhancement; LVEDVi, left ventricle end-diastolic volume indexed for BSA; LVEF, left ventricular ejection fraction; MBF, myocardial blood flow.